ReviewCancers2022
Acquired Mechanisms of Resistance to Osimertinib-The Next Challenge.
Alejandro Ríos-Hoyo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewCancers2022
Alejandro Ríos-Hoyo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.